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Currently available non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen,
diclofenac, indomethacin and flurbiprofen exhibit gastric toxicity. Long-term use of the-
se drugs has been associated with gastro-intestinal (GI) ulceration, bleeding and neph-
rotoxicity (1). The GI damage from NSAIDs is generally attributed to two factors, local
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In order to reduce the ulcerogenic effect of ibuprofen, its
carboxylic group has been converted into 5-membered
heterocyclic rings. Various 1,3,4-oxadiazoles (3–8, 16–21),
1,2,4-triazoles (22–27), 1,3,4-thiadiazoles (28–30), and 1,2,4-
-triazine (9) derivatives of ibuprofen were prepared by
cyclization of 2-(4-i-butylphenyl) propionic acid hydrazide
(2) and N1-[2-(4-i-butylphenyl)-propionyl]-N4-alkyl/aryl-
-thiosemicarbazides (10–15) under various reaction con-
ditions. The cyclized derivatives were screened for their
anti-inflammatory activity by the carrageenan induced
rat paw edema method and showed 50 to 86% inhibi-
tion, whereas the standard drug ibuprofen showed 92%
inhibition at the same oral dose. Five compounds, 7, 16,
18, 22 and 30 that showed more than 80% anti-inflamma-
tory activity were selected to study their analgesic, ulce-
rogenic and lipid peroxidation activities. All the tested
compounds showed a significant reduction in ulcerogenic
activity compared to ibuprofen through the severity index
0.5 to 0.8, vs. ibuprofen 1.8. The compounds, that show-
ed less ulcerogenic effect also produced less malondial-
dehyde content in gastric mucosa, which is one of the end
products of lipid peroxidation. The results of biological
studies showed that oxadiazole derivative 16 as the lead
molecule with maximum anti-inflammatory, analgesic and
minimum ulcerogenic and lipid peroxidation activities.
Keywords: ibuprofen derivatives, anti-inflammatory acti-
vity, ulcerogenicity, lipid peroxidation
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irritation by the carboxylic acid moiety, common to most NSAIDs (topical effect) and de-
creased tissue prostaglandin production, which undermines the physiological role of cy-
toprotective prostaglandins in maintaining the GI health and homeostasis (2, 3). The phar-
macological activity of NSAIDs is related to the suppression of prostaglandin biosynthesis
from arachidonic acid by inhibiting cyclooxygenases (COXs) (2, 4). Chronic use of NSAIDs,
including ibuprofen, may elicit appreciable GI toxicity (5); therefore, synthetic approach-
es based upon NSAIDs chemical modification have been undertaken with the aim of im-
proving the NSAID safety profile. Studies described that the derivatization of the carbo-
xylate function of representative NSAIDs, resulted in an increased anti-inflammatory
activity with reduced ulcerogenic effect (6, 7). Furthermore, certain compounds bearing
1,3,4-oxadiazole/thiadiazole and 1,2,4-triazole nucleus have been reported to possess
significant anti-inflammatory activity (8–11). In our attempt to discover new and useful
agents for treating inflammatory diseases, we have replaced the carboxylic acid group of
ibuprofen with additional heterocycles, which have been found to possess an interesting
profile of anti-inflammatory activity with significant reduction of their ulcerogenic ef-
fect. The heterocycles reported here are 1,3,4-oxadiazoles, 1,2,4-triazoles, 1,3,4-thiadia-
zoles and 1,2,4-triazine. These compounds were evaluated for their ability to provide
protection against the carrageenin induced rat paw edema. A few selected compounds
were also screened for analgesic, ulcerogenic and lipid peroxidation activities.
EXPERIMENTAL
Melting points were measured in open capillary tubes and are uncorrected. IR (KBr)
spectra were recorded on a Nicolet, 5PC FT-IR spectrometer (Browser Morner, USA) and
1H NMR spectra on a Bruker DRX-300 FT NMR (Bruker, Germany) spectrophotometer
using TMS as internal reference (chemical shift in d, ppm). Mass spectra were recorded
on a Jeol-JMS-D-300 mass spectrometer (70 eV) (Jeol, Japan). Purity of the compounds
was checked on silica gel G plates using iodine vapours as visualizing agents. 2-(4-i-
Butylphenyl)propionic acid (ibuprofen) was procured from Ace laboratories, India as a
gift sample. All reagents used in the present work were of analytical grade.
Ethyl-[2-(4-i-butylphenyl) propionate] (1) was prepared by the procedure given in
literature (12). 2-(4-i-Butylphenyl) propionic acid hydrazide (2) was prepared by the re-
ported procedure (9).
The synthetic pathway is given in Scheme 1 and characterization data of compo-
unds are given in Table I. Satisfactory analysis for C, H, N was obtained for all the com-
pounds within ± 0.4% of the theoretical values.
Syntheses
5-[2-(4-i-Butylphenyl)ethyl]-2-mercapto-1,3,4-oxadiazole (3). – A mixture of 2 (0.005 mol),
KOH (0.005 mol) and carbon disulphide (5 mL) in ethanol (50 mL) was refluxed on a
steam bath for 12 h. The solution was then concentrated, cooled and acidified with di-
luted HCl. The solid mass that precipitated was filtered, washed with ethanol, dried and
recrystallized from ethanol.
32
M. Amir and S. Kumar: Synthesis and evaluation of anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation properties of
ibuprofen derivatives, Acta Pharm. 57 (2007) 31–45.
5-[2-(4-i-Butylphenyl)ethyl]-2-amino-1,3,4-oxadiazole (4). – To an ethanolic solution of 2
(0.001 mol), cyanogen bromide (0.001 mol) was added. The reaction mixture was stirred
with heating at 55–56 °C for 2 h. The resulting solution was cooled and neutralized with
sodium bicarbonate solution. The solid thus precipitated was filtered, washed with wa-
ter, dried and recrystallized from methanol.
5-[2-(4-i-Butylphenyl)ethyl]-2-(aryl)-1,3,4-oxadiazoles (5–8). – Compound 2 (0.001 mol) and
the appropriate aromatic acid (0.001 mol) were dissolved in phosphorus oxychloride
33
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and refluxed for 18–26 h. The reaction mixture was slowly poured over crushed ice and
kept overnight. The solid thus precipitated was filtered, washed with water, dried and
recrystallized from ethanol.
3-[2-(4-i-Butylphenyl) ethyl]-1,2,5,6-tetrahydro-1,2,4-triazin-5-one (9). – To compound 2
(0.01 mol), chloroacetamide (0.01 mol) and dimethylformamide (80 mL) were added and
the reaction mixture was refluxed for 30 h. It was then concentrated and cooled, where-
upon the solid precipitated was filtered, washed with ethanol and recrystallized from
DMF/water (5:1, V/V).
N1-[2-(4-i-Butylphenyl) propionyl] N4-alkyl/aryl-thiosemicarbazides (10–15). – A mixture
of 2 (0.10 mol), alkyl/aryl i-thiocyanate (0.10 mol) and ethanol (50 mL) was refluxed on a
steam bath for 10 h. It was then concentrated, cooled and kept overnight in refrigerator.
The solid thus precipitated was filtered, washed with ethanol, dried and recrystallized
from ethanol.
5-[2-(4-i-Butylphenyl)ethyl]-2-alkyl/aryl-amino-1,3,4-oxadiazoles (16–21). – A suspensi-
on of 10–15 (0.002 mol) in ethanol (50 mL) was dissolved in aqueous sodium hydroxide (5
mol L–1, 1 mL) under cooling and stirring, resulting in a clear solution. To this, iodine in
potassium iodide solution (5%) was added gradually under stirring till the iodine colour
persisted at room temperature. The reaction mixture was then refluxed for 4–6 h on a
water bath. It was then cooled and poured over crushed ice. The solid mass that was
precipitated was filtered, dried and recrystallized from ethanol.
5-[2-(4-i-Butylphenyl)ethyl]-4-alkyl/aryl-3-mercapto-1,2,4(H)-triazoles (22–27). – A suspen-
sion of 10–15 (0.002 mol) in ethanol (25 mL) was dissolved in aqueous sodium hydrox-
ide (4 mol L–1, 2 mL) and gently refluxed for 6–8 h. The resulting solution was concen-
trated, cooled and filtered. The filtrate was adjusted to pH 5–6 with diluted acetic acid
and was kept aside for 1 h. The crystals produced were filtered, washed with water, dried
and recrystallized from ethanol.
5-[2-(4-i-Butylphenyl)ethyl]-2-alkyl/aryl-amino-1,3,4-thiadiazoles (28–30). – Thiosemicar-
bazide 10–15 (0.001 mol) was added gradually under stirring to cooled concentrated sul-
phuric acid (10 mL) for 10 minutes. The reaction mixture was further stirred for another
2–4 h in an ice bath. It was then poured over crushed ice under stirring. The solid pre-
cipitated was filtered, washed with water, dried and recrystallized with methanol.
Pharmacology
Wistar rats and albino mice used in the present study were housed and kept in ac-
cordance with the Hamdard University Animal Care Unit, which applies the guidelines
and rules laid down by the Committee for the Purpose of Control and Supervision of
Experiments on Animals (CPCSEA), Ministry of Social Justice and Empowerment, Gov-
ernment of India. Wistar rats and albino mice of either sex (Hamdard University, Animal
House, New Delhi, India), weighing 180–200 g (12 weeks) and 22–25 g (8 weeks), were
used. The animals were housed in groups of six and acclimatized to room conditions for
at least 2 days before the experiments. Food and water were freely available up to the
time of experiments. The food was withdrawn on the day before the experiment, but
free access to water was allowed.
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All the compounds (70 mg kg–1 body mass) and the reference NSAID ibuprofen (70
mg kg–1 body mass) were suspended in 1% carboxymethyl cellulose (CMC) and admini-
stered orally using an animal feeding needle. The control groups received appropriate
volumes of vehicle (1% CMC, oral) only.
Anti-inflammatory activity. – This activity was performed by the following procedure
of Winter et al. (13) on groups of six animals each. A freshly prepared suspension of car-
rageenin (1.0% m/V, 0.1 mL) was injected in the plantar region of the right hind paw of
each rat. One group was kept as control and the animals of the other group were pre-
treated with the test drugs (70 mg kg–1 body mass) suspended in 1.0% CMC given orally
1 h before the carrageenin treatment. The volume was measured before and after 4 h of
carrageenin treatment using a pleythysmometer.
Analgesic activity. – Mice were kept individually in the test cage before acetic acid in-
jection and habituated for 30 minutes. Screening of analgesic activity was performed af-
ter p.o. administration of test drugs at a dose of 70 mg kg–1 body mass. The compounds,
which exhibited good anti-inflammatory activity comparable to that of ibuprofen, were
screened for analgesic activity. All compounds were dissolved in 1.0% CMC solution.
One group was kept as control and received p.o. 1% CMC. After 1 h of drug administra-
tion, 0.10 mL of 1% acetic acid solution was given to mice intraperitoneally. The acetic
acid induced writhing test (14) showed stretching movements involving arching of the
back, elongation of the body and extension of hind limbs which were counted for 5–15
minutes of acetic acid injection.
Acute ulcerogenesis. – Acute ulcerogenesis test was done according to Cioli et al. (15).
Wistar rats were divided into different groups consisting of six animals each. Ulcerogen-
ic activity was evaluated after p.o. administration of test compounds or ibuprofen at the
dose of 200 mg kg–1 body mass. Control rats received p.o. the vehicle (suspension of 1%
methylcellulose). Food but not water was removed 24 h before administration of the test
compounds. After the drug treatment, the rats were fed normal diet for 17 h and were
then sacrificed. The stomach was removed and opened along the greater curvature, wash-
ed with distilled water and cleaned gently by dipping in saline. The mucosal damage was
examined by means of a magnifying glass. For each stomach the mucosal damage was
assessed according to the following scoring system: 0.5 redness; 1.0 spot ulcers; 1.5 hem-
orrhagic streaks; 2.0 ulcers > 3 but £ 5; 3.0 ulcers > 5.
The mean score of each treated group minus the mean score of control group was
regarded as the severity index of gastric mucosal damage.
Lipid peroxidation. – Lipid peroxidation in the gastric mucosa was determined accord-
ing to the method of Ohkawa et al. (16). After screening for ulcerogenic activity, the gas-
tric mucosa was scraped with two glass slides, weighed (100 mg) and homogenized in
1.8 mL of 1.15% ice cold KCl solution. The homogenate was supplemented with 0.2 mL
of 8.1% sodium dodecyl sulfate (SDS), 1.5 mL of acetate buffer (pH = 3.5) and 1.5 mL of
0.8% thiobarbituric acid (TBA). The mixture was heated at 95 °C for 60 minutes. After
cooling, the reactants were supplemented with 5 mL of the mixture of n-butanol/pyri-
dine (15:1 V/V), shaken vigorously for 1 minute and centrifuged for 10 minutes at 4000
rpm. The supernatant organic layer was taken out and absorbance was measured at 532
nm on a UV spectrophotometer. The results were expressed as nmol malondialdehyde
(MDA) per 100 mg tissue, using a molar absorption coefficient of 1.56 × 105 cm–1 mol–1 (17).
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All the pharmacological data are expressed as mean ± SEM; Student’s t-test was ap-
plied to determine the significance of the difference between the control group and groups
of animals treated with the test compounds.
RESULTS AND DISCUSSION
The acid hydrazide 2 was prepared by esterification of 2-(4-i-butylphenyl) propionic
acid followed by treatment with hydrazine hydrate in absolute ethanol. The reaction of
hydrazide 2 with carbon disulphide in alkaline medium afforded, after acidic treatment,
5-[2-(4-i-butylphenyl)ethyl]-2-mercapto-1,3,4-oxadiazole (3). The IR spectrum of compo-
und 3 revealed the presence of absorption bands at 1140 cm-1 for C=S group and at 1652
cm-1 due to C=N stretching vibrations. Also, the 1H NMR spectrum of 3 showed a sin-
glet at d 10.53 ppm for the SH proton, confirming the formation of a mercapto triazole
ring. The mass spectra showed the molecular ion peak M+ at m/z 262 corresponding to
the molecular formula C14H18N2OS. Treatment of hydrazide with cyanogen bromide af-
forded 5-[2-(4-i-butylphenyl)ethyl]-2-amino-1,3,4-oxadiazole (4). The IR spectrum of com-
pound 4 showed absorption peaks at 1640 cm-1 due to C=N stretching vibrations. Also,
the 1H NMR spectrum of compounds is in agreement with its structure, which revealed
a singlet at d 6.17 due to the NH2 proton attached to the 2nd position of oxadiazole ring.
The mass spectra showed the molecular ion peak M+ at m/z 245 corresponding to the
molecular formula C14H19N3O. Various 2-aryl-1,3,4-oxadiazoles 5–8 were prepared by tre-
atment of hydrazide with appropriate aromatic acids in the presence of phosphorus oxy-
chloride. The structure of oxadiazole 8 was established by its IR spectrum, which show-
ed an absorption peak at 1645 cm–1 due to C=N stretching vibrations. The compound 1H
NMR spectra displayed a singlet at d 6.59 attributed to NH2 protons and a multiplet at d
7.33–7.68 for 8 ArH protons. The mass spectra showed the molecular ion peak M+ at m/z
321 corresponding to the molecular formula C20H23N3O. 3-[2-(4-i-Butylphenyl)ethyl]-
-1,2,5,6-tetrahydro-1,2,4-triazine-5-one (9) was prepared by condensation of hydrazide
with chloroacetamide. The structure of compound was confirmed by appearance of ab-
sorption peaks at 1588 cm–1 due to C=N and 1648 cm–1 corresponding to C=O group.
The 1H NMR spectrum of compounds showed a singlet at d 2.43 ppm for CH2 proton of
triazinone ring. The presence of two broad singlets at d 5.38 and 6.07 ppm for NH pro-
tons also confirms the formation of the compound. The mass spectra of compound 9 show-
ed molecular ion peak M+ at m/z 259 corresponding to molecular formula C15H21N3O.
Furthermore, hydrazide 2 on treatment with various alkyl/aryl i-thiocyanates gave
N1-[2-(4-i-butylphenyl)propionyl]-N4-alkyl/arylthiosemicarbazides (10–15). The structu-
re of thiosemicarbazide 10 was confirmed by its IR spectrum, which displayed absorp-
tion bands at 3337 cm–1 for NH, 1665 cm–1 due to C=O and 1160 cm–1 corresponding to
C=S stretch vibrations. The 1H NMR spectrum showed a multiplet at d 7.11–7.26 ppm
for 4 ArH protons. The CSNH and CONH protons were observed as a singlet at d 8.62
and 9.04 ppm, respectively, confirming the formation of thiosemicarbazide. The mass
spectra showed molecular ion peak M+ at m/z 335 corresponding to molecular formula
C18H29N3OS.
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The thiosemicarbazides were oxidatively cyclised to 2-alkyl/arylamino-5-substitut-
ed-1,3,4-oxadiazoles (16–21) by elimination of H2S using iodine and potassium iodide in
ethanolic sodium hydroxide. The IR spectrum of oxadiazole 16 showed absorption peak
at 1560 cm–1 due to C=N stretch vibration. The structure was further supported by its 1H
NMR spectrum, which showed a multiplet at d 6.91–7.15 ppm for 4 ArH and 1 NH pro-
tons. The mass spectra showed molecular ion peak M+ at m/z 301 corresponding to mo-
lecular formula C18H27N3O. The thiosemicarbazides 10–15 on heating with 4 mol L–1
NaOH in ethanol underwent smooth cyclisation through dehydration to afford 5-substi-
tuted-4-alkyl/aryl-3-mercapto-4H-1,2,4-triazoles (22–27). The structure of triazole 22 was
confirmed by its IR spectrum, which displayed absorption peak at 1560 cm–1 due to C=N
and at 1080 cm–1 corresponding to C=S group. The formation of triazole ring was fur-
ther supported by its 1H NMR spectrum, which showed a triplet for NCH2 proton at d
3.56 ppm. A singlet for SH proton was also observed at d 11.10 ppm. The mass spectra of
the compound 22 showed molecular ion peak M+ at m/z 317 corresponding to molecular
formula C18H27N3S. 2-Alkyl/arylamino-5-substituted-1,3,4-thiadiazoles (28–30) were ob-
tained by cyclisation of 10–15 by treating with cold concentrated sulphuric acid. The IR
spectrum of compound 30 showed absorption peak at 1620 cm–1 due to C=N stretching
vibration. In the 1H NMR spectrum of the compound the singlet of CSNH and CONH of
thiosemicarbazide disappeared and a multiplet was obtained in the aromatic region at d
7.26–7.69 ppm for 8 ArH protons. The NH proton was observed as a singlet at d 8.17 con-
firming he structure of compound. The mass spectra of the compound 30 showed molec-
ular ion peak M+ at m/z 371 corresponding to molecular formula C20H22ClN3S.
The anti-inflammatory activity of the synthesized compounds 3, 4, 7, 9, 16–19, 21–24,
27–30 were evaluated by the carrageenin induced paw edema method. The compounds
were tested at an oral dose of 70 mg kg–1 body mass and were compared with the stan-
dard drug ibuprofen at the same oral dose. The tested compounds showed anti-inflam-
matory activity ranging from 50 to 86% (Table II), and the standard drug ibuprofen showed
92% inhibition after 4 hours. The oxadiazole derivative 16 having an n-butyl amino group
showed the maximum activity (86%), whereas when this group was replaced by the cy-
clohexyl amino group 17 the activity was found to be minimal (50%). It was observed
that oxadiazole derivatives having p-chlorophenyl amino, o-methoxyphenyl amino and
2,4-dichloromethoxyphenyl groups at the 2nd position showed high activity (85, 79 and
82%), respectively. When these groups were replaced by p-fluorophenyl amino (19), 2-
mercapto (3) and 2-amino (4) groups, the activity was found to be reduced.
The 1,2,4-triazole derivatives of ibuprofen showed anti-inflammatory activity rang-
ing from 68 to 82%. The highest activity was found for the triazole derivatives 22 and 27
(82%), having the n-butyl group and o-methoxyphenyl group at position 4. When these
groups were replaced by the cyclohexyl group in compound 23, the activity was found
to be minimal (68%). The triazole derivative 24 having the p-chlorophenyl group show-
ed moderate activity.
The 1,3,4-thiadiazole derivatives of ibuprofen showed anti-inflammatory activity rang-
ing from 75 to 84%. Maximum activity was shown by the thiadiazole derivative 30 hav-
ing the p-chlorophenyl amino group at position 2. When this group was replaced by the
n-butyl amino group in derivative 28, the activity was found to be decreased (75%), whe-
reas in case of oxadiazole and triazole derivatives the compound having the n-butyl group
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showed highest activity. When the hydrazide of ibuprofen was treated with 2-chloroace-
tamide, 1,2,4-triazine derivative was obtained, which also showed significant anti-inflam-
matory activity (71%).
The compounds that showed anti-inflammatory activity higher than 80% were test-
ed for analgesic activity. Compounds 7, 16, 18, 22 and 30 showed analgesic activity rang-
ing from 57 to 73%, whereas the standard drug ibuprofen showed 84% at a 70 mg kg–1
oral dose. Among all the tested compounds, the oxadiazole derivative having the n-bu-
tyl amino group 16 showed maximum activity (73%). When this group was replaced by
the p-chlorophenyl amino (18) and 2,4-dichloromethoxyphenyl group (7), there was a
significant decrease in the activity. Among all the tested compounds, thiadiazole 30 show-
ed minimum activity (57%), whereas triazole derivative 22 showed significant analgesic
activity (71%).
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Control – – 0.0 ± 0.0b 3.37 ± 0.01b
3 70 69 ± 3.0b – – – – –
4 70 75 ± 1.7b – – – –
7 70 82 ± 1.7c 70 57 ± 0.9b 200 0.6 ± 0.1c 3.96 ± 0.15c
9 70 71 ± 5.0d – – – – –
16 70 86 ± 1.7e 70 73 ± 0.9b 200 0.5 ± 0.2b 3.85 ± 0.14b
17 70 50 ± 3.0b – – – – –
18 70 85 ± 1.9e 70 59 ± 0.5b 200 0.8 ± 0.2d 4.26 ± 0.15d
19 70 71 ± 2.6b – – – – –
21 70 79 ± 0.8b – – – –
22 70 82 ± 0.9b 70 71 ± 1.2b 200 0.6 ± 0.2c 3.99 ± 0.15c
23 70 68 ± 2.7b – – – – –
24 70 76 ± 2.1b – – – – –
27 70 82 ± 2.0d – – – – –
28 70 75 ± 2.0b – – – – –
29 70 76 ± 3.0c – – – – –
30 70 84 ± 2.0d 70 56.6 ± 1.1b 200 0.5 ± 0.0b 3.80 ± 0.10b
Ibuprofen 70 92 ± 1.0 70 83.5 ± 0.7b 200 1.8 ± 0.2 5.05 ± 0.14
a n = 6.
Anti-inflammatory and analgesic activities of the test compounds were measured with respect to the control
and compared with respect to the standard drug; ulcerogenic and lipid peroxidation were compared with re-
spect to standard drug.
b p < 0.0001, c p < 0.001, d p < 0.05.
The compounds that were screened for analgesic activity were further screened for
their ulcerogenic activity. All the compounds were tested at an oral dose of 200 mg kg–1
body mass. The maximum reduction in ulcerogenic activity (mean severity index ± SEM,
n = 6) was 0.5 ± 0.2), found in oxadiazole derivative 16, having the n-butyl amino group
at position 2. In thiadiazole derivative, maximum reduction (0.5 ± 0) was found in com-
pound 30, having the p-chlorophenyl amino group, whereas the same group present in
oxadiazole derivative 18 showed the maximum severity index (0.8 ± 0.2). The other two
compounds, 7 and 22, oxadiazole and triazole derivatives, respectively, showed moder-
ate severity indexes. The standard drug ibuprofen showed a high severity index of 1.8 ±
0.2.
It has been reported in the literature that lower ulcerogenic activity of compounds is
combined with a reduced malondialdehyde (MDA) content in the affected area of the
gastrointestinal tract, end products of lipid peroxidation (18, 19). Therefore, an attempt
was made to correlate the decrease in ulcerogenic activity of the compounds with that of
lipid peroxidation. All the compounds screened for ulcerogenic activity were also ana-
lyzed for lipid peroxidation. Lipid peroxidation is measured as nmol of MDA per 100
mg of gastric mucosa tissue. The ibuprofen (standard drug) showed the highest lipid
peroxidation (5.05 ± 0.14), whereas the control group showed 3.37 ± 0.01. It was found
that all the cyclized derivatives showing less ulcerogenic activity also showed a reduc-
tion in lipid peroxidation (Table II). Thus, these studies show that synthesized compo-
unds have inhibited the induction of gastric mucosal lesions and the results further sug-
gested that their protective effect might be related to the inhibition of lipid peroxidation
in the gastric mucosa.
CONCLUSIONS
Various oxadiazole, triazole, thiadiazole and triazine derivatives of ibuprofen were
prepared with the objective of developing better anti-inflammatory molecules with mini-
mal ulcerogenic activity. Among these, an oxadiazole derivative of ibuprofen, 5-[2-(4-i-
butylphenyl) ethyl]-n-butyl amino-1,3,4-oxadiazole derivative showed maximum activ-
ity (86%). It also showed maximum analgesic activity, maximum reduction of the sever-
ity index along with minimum lipid peroxidation.
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S A @ E T A K
Sinteza i procjena protuupalnog, analgetskog i ulcerogenog djelovanja derivata
ibuprofena, te njihovog u~inka na peroksidaciju lipida
MOHAMMAD AMIR i SHIKHA KUMAR
Karboksilna skupina ibuprofena prevedena je u petero~lane heterocikli~ke prstene
da se smanji ulcerogeni u~inak. Pripravljeni su razli~iti 1,3,4-oksadiazoli (3–8, 16–21),
1,2,4-triazoli (22–27), 1,3,4-tiadiazoli (28–30) i 1,2,4-triazin (9) ciklizacijom hidrazida 2-(4-
-i-butilfenil) propanske kiseline i N’-[2-(4-i-butilfenil)propionil]-N4-alkil/aril tiosemikar-
bazida (10–15) uz razli~ite reakcijske uvjete. Heterocikli~ki derivati ibuprofena su u test-
ovima na protuupalno djelovanje na edem {ape induciran karageninom pokazali inhibitorni
u~inak od 50–86%, dok je sam ibuprofen u istoj dozi inhibirao 92%. Spojevi koji su inhibirali
edem za vi{e od 80% (7, 16, 18 i 22) testirani su na analgetsko i ulcerogeno djelovanje, te
na sposobnost peroksidacije lipida. Svi testirani spojevi imaju zna~ajno smanjenu ulce-
rogenost u rasponu 0,5 ± 0,0 do 0,8 ± 0,2, dok je ibuprofen imao najve}i indeks 1,8 ± 0,2.
Spojevi koji su pokazali manji ulcerogeni u~inak smanjivali su i produkciju malondial-
dehida u sluznici `eluca, krajnjeg produkta peroksidacije lipida. Najja~i protuupalni i anal-
getski u~inak, a ujedno najmanju ulcerogenost i najmanju peroksidaciju lipida, pokazao
je oksadiazolski derivat 16.
Klju~ne rije~i: derivati ibuprofena, protuupalno djelovanje, ulcerogenost, peroksidacija lipida
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